Mimedx (MDXG) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.51% |
| Dec 31, 2025 | -16.25% |
| Sep 30, 2025 | -13.37% |
| Jun 30, 2025 | -13.01% |
| Mar 31, 2025 | -13.37% |
| Dec 31, 2024 | -13.58% |
| Sep 30, 2024 | -13.32% |
| Jun 30, 2024 | -14.20% |
| Mar 31, 2024 | -14.83% |
| Dec 31, 2023 | -16.73% |
| Dec 31, 2022 | -11.03% |
| Sep 30, 2022 | -9.82% |
| Jun 30, 2022 | -10.40% |
| Mar 31, 2022 | -8.64% |
| Dec 31, 2021 | -8.10% |
| Sep 30, 2021 | -6.45% |
| Jun 30, 2021 | -4.67% |
| Mar 31, 2021 | -1.85% |
| Dec 31, 2020 | 3.84% |
| Sep 30, 2020 | 4.13% |
| Jun 30, 2020 | 8.54% |
| Mar 31, 2020 | 12.94% |
| Dec 31, 2019 | 17.75% |
| Sep 30, 2019 | 21.14% |
| Jun 30, 2019 | 25.67% |
| Mar 31, 2019 | 30.73% |
| Dec 31, 2018 | 33.65% |
| Dec 31, 2017 | 67.41% |
| Sep 30, 2017 | 67.71% |
| Jun 30, 2017 | 72.33% |
| Mar 31, 2017 | 76.40% |
| Dec 31, 2016 | 74.30% |
| Sep 30, 2016 | 71.89% |
| Jun 30, 2016 | 77.46% |
| Dec 31, 2015 | 65.77% |